These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10962239)
61. Compression of pellets coated with various aqueous polymer dispersions. Dashevsky A; Kolter K; Bodmeier R Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790 [TBL] [Abstract][Full Text] [Related]
62. Aqueous ethyl cellulose dispersion containing plasticizers of different water solubility and hydroxypropyl methyl-cellulose as coating material for diffusion pellets II: properties of sprayed films. Frohoff-Hülsmann MA; Lippold BC; McGinity JW Eur J Pharm Biopharm; 1999 Jul; 48(1):67-75. PubMed ID: 10477331 [TBL] [Abstract][Full Text] [Related]
63. Comparison of physicomechanical properties of films prepared from organic solutions and aqueous dispersion of Eudragit RL. Sadeghi F; Shahabi M; Afrasiabi H Daru; 2011; 19(2):100-6. PubMed ID: 22615646 [TBL] [Abstract][Full Text] [Related]
64. The influence of plasticizers on the release of theophylline from microporous-controlled tablets. Lin WJ; Lee HK; Wang DM J Control Release; 2004 Oct; 99(3):415-21. PubMed ID: 15451599 [TBL] [Abstract][Full Text] [Related]
65. Water-solid interactions. IV. Influence of moisture sorption on the compaction of film-coated particles. Stubberud L; Eriksson M; Kordnejad K; Graffner C Pharm Dev Technol; 1998 May; 3(2):141-51. PubMed ID: 9653751 [TBL] [Abstract][Full Text] [Related]
66. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films. Wagner K; McGinity J J Control Release; 2002 Aug; 82(2-3):385-97. PubMed ID: 12175751 [TBL] [Abstract][Full Text] [Related]
67. Polymerized rosin: novel film forming polymer for drug delivery. Fulzele SV; Satturwar PM; Dorle AK Int J Pharm; 2002 Dec; 249(1-2):175-84. PubMed ID: 12433446 [TBL] [Abstract][Full Text] [Related]
68. Dry powder coating of pellets with micronized Eudragit RS for extended drug release. Pearnchob N; Bodmeier R Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361 [TBL] [Abstract][Full Text] [Related]
69. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
70. Development of matrix-based theophylline sustained-release microtablets. Rey H; Wagner KG; Wehrlé P; Schmidt PC Drug Dev Ind Pharm; 2000 Jan; 26(1):21-6. PubMed ID: 10677806 [TBL] [Abstract][Full Text] [Related]
71. When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS. Karrout Y; Siepmann F; Benzine Y; Paccou L; Guinet Y; Hedoux A; Siepmann J Int J Pharm; 2018 Mar; 539(1-2):39-49. PubMed ID: 29337184 [TBL] [Abstract][Full Text] [Related]
72. Transport and tensile properties of compression-molded wheat gluten films. Gällstedt M; Mattozzi A; Johansson E; Hedenqvist MS Biomacromolecules; 2004; 5(5):2020-8. PubMed ID: 15360319 [TBL] [Abstract][Full Text] [Related]
73. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Bruce LD; Koleng JJ; McGinity JW Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312 [TBL] [Abstract][Full Text] [Related]
74. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature. Dave VS; Fahmy RM; Hoag SW Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574 [TBL] [Abstract][Full Text] [Related]
75. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release. Ghanam D; Kleinebudde P Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073 [TBL] [Abstract][Full Text] [Related]
76. Applying a novel electrostatic dry powder coating technology to pellets. Yang Q; Ma Y; Zhu J Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275 [TBL] [Abstract][Full Text] [Related]
77. Preparation and stability investigation of tamsulosin hydrochloride sustained release pellets containing acrylic resin polymers with two different techniques. Fan R; Sun Y; Li B; Yang R; Ma W; Sun J Asian J Pharm Sci; 2017 Mar; 12(2):193-201. PubMed ID: 32104330 [TBL] [Abstract][Full Text] [Related]
79. Prediction of Optimum Combination of Eudragit RS/Eudragit RL/Ethyl Cellulose Polymeric Free Films Based on Experimental Design for Using as a Coating System for Sustained Release Theophylline Pellets. Akhgari A; Tavakol A Adv Pharm Bull; 2016 Jun; 6(2):219-25. PubMed ID: 27478784 [TBL] [Abstract][Full Text] [Related]
80. Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55. Sauer D; McGinity J Pharm Dev Technol; 2009 Apr; ():. PubMed ID: 19552552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]